Clinicopathological and prognostic value of Ki-67 expression in oral malignant melanoma: A systematic review and meta-analysis
- PMID: 36704188
- PMCID: PMC9871167
- DOI: 10.34172/joddd.2022.024
Clinicopathological and prognostic value of Ki-67 expression in oral malignant melanoma: A systematic review and meta-analysis
Abstract
Background. Ki-67 is one of the new biological markers with clinical value in the pathology and prognosis of oral melanoma. It is a nuclear protein involved in regulating cell proliferation. Some studies have suggested an association between Ki-67 and poor survival in patients with oral melanoma. This systematic review was undertaken to clarify this issue. Methods. Databases of PubMed, Scopus, and Web of Science were searched using relevant English keywords from 1988 to April 2022. STATA software version 16 and random models were used for meta-analysis. Results. Eleven articles were included in this systematic review, six of which were selected for meta-analysis. The mean expression of the Ki-67 index in patients with oral melanoma was estimated at 43.81% (28.66‒58.95 with 95% CI, I2=94.2, P<0.001). In addition, the results showed a significant relationship between Ki-67 expression and the prognosis of oral melanoma lesions. Increased expression of this marker weakens the prognosis and decreases the survival rate. Conclusion. High expression of Ki-67 may serve as a predictive biomarker for poor prognosis in patients with malignant oral melanoma. Therefore, classifying this malignancy by Ki-67 expression may be considered for therapy regimen selection and integrated management.
Keywords: Ki-67; Meta-analysis; Oral malignant melanoma; Prognosis.
©2022 The Author(s).
Similar articles
-
Expression of Ki-67 in Oral Lichen Planus: A Systematic Review and Meta-Analysis.J Dent (Shiraz). 2024 Dec 1;25(4):288-295. doi: 10.30476/dentjods.2023.98491.2082. eCollection 2024 Dec. J Dent (Shiraz). 2024. PMID: 39713114 Free PMC article. Review.
-
Prognostic and Clinicopathological Value of Ki-67 in Melanoma: A Meta-Analysis.Front Oncol. 2021 Sep 8;11:737760. doi: 10.3389/fonc.2021.737760. eCollection 2021. Front Oncol. 2021. PMID: 34568073 Free PMC article.
-
Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis.PLoS One. 2015 Jun 3;10(6):e0129028. doi: 10.1371/journal.pone.0129028. eCollection 2015. PLoS One. 2015. PMID: 26038827 Free PMC article.
-
High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.Medicine (Baltimore). 2016 Apr;95(15):e3337. doi: 10.1097/MD.0000000000003337. Medicine (Baltimore). 2016. PMID: 27082587 Free PMC article. Review.
-
Prognostic and clinicopathological value of Ki-67 expression in patients with nasopharyngeal carcinoma: a meta-analysis.Ther Adv Med Oncol. 2020 Sep 20;12:1758835920951346. doi: 10.1177/1758835920951346. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33014147 Free PMC article.
Cited by
-
Exploratory analyses of the associations between Ki-67 expression, lymph node metastasis, and prognosis in patients with esophageal squamous cell cancer.PeerJ. 2025 Feb 26;13:e19062. doi: 10.7717/peerj.19062. eCollection 2025. PeerJ. 2025. PMID: 40028218 Free PMC article.
-
Expression of Ki-67 in Oral Lichen Planus: A Systematic Review and Meta-Analysis.J Dent (Shiraz). 2024 Dec 1;25(4):288-295. doi: 10.30476/dentjods.2023.98491.2082. eCollection 2024 Dec. J Dent (Shiraz). 2024. PMID: 39713114 Free PMC article. Review.
-
Prognostic and clinicopathological value of Ki-67 in patients with oesophageal squamous cell carcinoma: a systematic review and meta-analysis.BMJ Open. 2024 Jun 5;14(6):e083637. doi: 10.1136/bmjopen-2023-083637. BMJ Open. 2024. PMID: 38839387 Free PMC article.
-
The SEB1741 Aptamer Is an Efficient Tool for Blocking CD4+ T Cell Activation Induced by Staphylococcal Enterotoxin B.Molecules. 2023 Apr 14;28(8):3480. doi: 10.3390/molecules28083480. Molecules. 2023. PMID: 37110712 Free PMC article.
-
Engineered Perfluorochemical Cancer-Derived Exosomes Loaded with Indocyanine Green and Camptothecin Provide Targeted Photochemotherapy for Effective Cancer Treatment.Int J Nanomedicine. 2025 Jan 8;20:327-342. doi: 10.2147/IJN.S505458. eCollection 2025. Int J Nanomedicine. 2025. PMID: 39802383 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous